Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 16, 2024

BUY
$15.14 - $22.99 $312,005 - $473,777
20,608 New
20,608 $442 Million
Q1 2024

Apr 19, 2024

SELL
$15.35 - $18.82 $94,356 - $115,686
-6,147 Reduced 23.01%
20,563 $381 Million
Q3 2023

Nov 03, 2023

BUY
$10.81 - $22.96 $105,538 - $224,158
9,763 Added 57.61%
26,710 $368,000
Q2 2023

Jul 14, 2023

SELL
$17.19 - $24.34 $24,083 - $34,100
-1,401 Reduced 7.64%
16,947 $374,000
Q1 2023

Apr 12, 2023

BUY
$17.67 - $26.07 $88 - $130
5 Added 0.03%
18,348 $399,000
Q3 2022

Oct 26, 2022

BUY
$14.64 - $26.7 $114,865 - $209,488
7,846 Added 74.75%
18,343 $417,000
Q2 2022

Jul 20, 2022

SELL
$10.54 - $24.2 $305 - $701
-29 Reduced 0.28%
10,497 $145,000
Q1 2022

May 02, 2022

BUY
$20.81 - $37.29 $624 - $1,118
30 Added 0.29%
10,526 $239,000
Q4 2021

Jan 14, 2022

SELL
$32.99 - $58.55 $42,985 - $76,290
-1,303 Reduced 11.04%
10,496 $391,000
Q3 2021

Oct 20, 2021

SELL
$42.03 - $60.5 $117,347 - $168,916
-2,792 Reduced 19.14%
11,799 $499,000
Q2 2021

Jul 23, 2021

BUY
$29.51 - $44.62 $6,669 - $10,084
226 Added 1.57%
14,591 $649,000
Q1 2021

Apr 14, 2021

SELL
$32.95 - $44.24 $3,360 - $4,512
-102 Reduced 0.71%
14,365 $517,000
Q4 2020

Jan 14, 2021

BUY
$27.5 - $45.75 $1,842 - $3,065
67 Added 0.47%
14,467 $577,000
Q3 2020

Oct 13, 2020

SELL
$16.04 - $28.94 $163,784 - $295,506
-10,211 Reduced 41.49%
14,400 $417,000
Q2 2020

Jul 22, 2020

SELL
$9.2 - $17.06 $5,492 - $10,184
-597 Reduced 2.37%
24,611 $402,000
Q1 2020

Apr 09, 2020

SELL
$8.36 - $17.03 $2,014 - $4,104
-241 Reduced 0.95%
25,208 $239,000
Q4 2019

Jan 09, 2020

SELL
$14.59 - $18.9 $12,168 - $15,762
-834 Reduced 3.17%
25,449 $412,000
Q3 2019

Oct 30, 2019

BUY
$15.7 - $20.98 $412,643 - $551,417
26,283 New
26,283 $437,000

Others Institutions Holding BLFS

About BIOLIFE SOLUTIONS INC


  • Ticker BLFS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 42,684,400
  • Market Cap $1.02B
  • Description
  • BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...
More about BLFS
Track This Portfolio

Track Mesirow Financial Investment Management, Inc. Portfolio

Follow Mesirow Financial Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.